[{"orgOrder":0,"company":"Xiamen Innovax Biotech","sponsor":"Center for Disease Control and Prevention, Fujian","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CHINA","productType":"Vaccine","year":"2024","type":"Inapplicable","leadProduct":"Recombinant Hepatitis E Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Xiamen Innovax Biotech","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular","sponsorNew":"Xiamen Innovax Biotech \/ Center for Disease Control and Prevention, Fujian","highestDevelopmentStatusID":"11","companyTruncated":"Xiamen Innovax Biotech \/ Center for Disease Control and Prevention, Fujian"},{"orgOrder":0,"company":"Xiamen Innovax Biotech","sponsor":"Xiamen Innovax Biotech","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"","productType":"Vaccine","year":"2025","type":"Inapplicable","leadProduct":"Human Papillomavirus 9-valent Vaccine, Recombinant","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase III","graph3":"Xiamen Innovax Biotech","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"Xiamen Innovax Biotech \/ Xiamen Innovax Biotech","highestDevelopmentStatusID":"10","companyTruncated":"Xiamen Innovax Biotech \/ Xiamen Innovax Biotech"},{"orgOrder":0,"company":"Xiamen Innovax Biotech","sponsor":"Jiangsu Province Centers for Disease Control and Prevention | Dongtai City Centers for Disease Control and Prevention","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"CHINA","productType":"Vaccine","year":"2022","type":"Inapplicable","leadProduct":"Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine","moa":"Undisclosed","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Phase IV","graph3":"Xiamen Innovax Biotech","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Oral Pill","sponsorNew":"Xiamen Innovax Biotech \/ Jiangsu Province Centers for Disease Control and Prevention | Dongtai City Centers for Disease Control and Prevention","highestDevelopmentStatusID":"11","companyTruncated":"Xiamen Innovax Biotech \/ Jiangsu Province Centers for Disease Control and Prevention | Dongtai City Centers for Disease Control and Prevention"},{"orgOrder":0,"company":"Xiamen Innovax Biotech","sponsor":"Zhejiang Provincial CDC","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CHINA","productType":"Vaccine","year":"2022","type":"Inapplicable","leadProduct":"Bivalent Hpv Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Xiamen Innovax Biotech","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Xiamen Innovax Biotech \/ Zhejiang Provincial CDC","highestDevelopmentStatusID":"11","companyTruncated":"Xiamen Innovax Biotech \/ Zhejiang Provincial CDC"},{"orgOrder":0,"company":"Xiamen Innovax Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"CHINA","productType":"Vaccine","year":"2024","type":"Inapplicable","leadProduct":"Human Papillomavirus Vaccine","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase IV","graph3":"Xiamen Innovax Biotech","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Xiamen Innovax Biotech \/ Inapplicable","highestDevelopmentStatusID":"11","companyTruncated":"Xiamen Innovax Biotech \/ Inapplicable"},{"orgOrder":0,"company":"Xiamen Innovax Biotech","sponsor":"GSK","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"UNITED KINGDOM","productType":"Other Small Molecule","year":"2020","type":"Agreement","leadProduct":"AS03","moa":"||Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Xiamen Innovax Biotech","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Xiamen Innovax Biotech \/ Xiamen Innovax Biotech","highestDevelopmentStatusID":"1","companyTruncated":"Xiamen Innovax Biotech \/ Xiamen Innovax Biotech"}]

Find Clinical Drug Pipeline Developments & Deals by Xiamen Innovax Biotech

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check all FDF Dossiers for
this supplier

Contact Us
PharmaScopic.com

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Xiamen Innovax Biotech

China

ChemOutsourcing

Not Confirmed

02

Xiamen Innovax Biotech

China

ChemOutsourcing

Not Confirmed

03

Xiamen Innovax Biotech

China

ChemOutsourcing

Not Confirmed

04

Xiamen Innovax Biotech

China

ChemOutsourcing

Not Confirmed

05

Xiamen Innovax Biotech

China

ChemOutsourcing

Not Confirmed

06

Xiamen Innovax Biotech

China

ChemOutsourcing

Not Confirmed

07

Xiamen Innovax Biotech

China

ChemOutsourcing

Not Confirmed

08

Xiamen Innovax Biotech

China

ChemOutsourcing

Not Confirmed

09

Xiamen Innovax Biotech

China

ChemOutsourcing

Not Confirmed

10

Xiamen Innovax Biotech

China

ChemOutsourcing

Not Confirmed

1
2